Intermountain Healthcare is the famous Corporate Investor, which was founded in 1975. The main department of described Corporate Investor is located in the Salt Lake City. The fund was located in North America if to be more exact in United States.
Among the most popular portfolio startups of the fund, we may highlight Redox, Tissue Analytics, Tute Genomics. Among the most popular fund investment industries, there are Data Integration, Genetics. The fund has exact preference in some founders of portfolio startups. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Intermountain Healthcare, startups are often financed by Dreamit Ventures, HealthX Ventures, Flybridge Capital Partners. The meaningful sponsors for the fund in investment in the same round are .406 Ventures, RRE Ventures, Marc Benioff. In the next rounds fund is usually obtained by .406 Ventures, RRE Ventures, HealthX Ventures.
This Intermountain Healthcare works on 16 percentage points less the average amount of lead investments comparing to the other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars. The top amount of exits for fund were in 2016. Speaking about the real fund results, this Corporate Investor is 13 percentage points more often commits exit comparing to other organizations. When the investment is from Intermountain Healthcare the average startup value is 500 millions - 1 billion dollars. The fund is generally included in 2-6 deals every year. The important activity for fund was in 2018. Despite it in 2019 the fund had an activity.
Fund Name | Location |
Anhui Shengyun Environment-Protection Group | Anhui, China, Hefei |
BASF | Germany, Ludwigshafen Am Rhein-oggersheim, Rheinland-Pfalz |
Basset Investment Group | New York, New York, United States |
Boston MedTech Advisors | Dedham, Massachusetts, United States |
Cain International | England, London, United Kingdom |
Epublica | Germany, Hamburg |
ESA Business Incubation Centre UK | - |
Impact Investment Exchange (IIX) | Central, Central Region, Singapore |
nbkc bank | Kansas, Overland Park, United States |
Nike Accelerator | Beaverton, Oregon, United States |
NSF Small Business Innovation Research / Small Business Technology Transfer (SBIR/STTR) | Arlington, United States, Virginia |
Origin House | Canada, Ontario, Ottawa |
Picante Capital | - |
Puma Private Equity | England, London, United Kingdom |
Red River Ventures | Mckinney, Texas, United States |
Revelation Partners | California, San Francisco, United States |
Sanxia Jinshi Investment Fund | - |
TOHO GAS | Aichi Prefecture, Japan, Nagoya |
Tongcheng Zichan | China, Shanghai |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Foodsmart by Zipongo | $10M | 31 Jan 2024 | San Francisco, California, United States | ||
CTRL Therapeutics | $10M | 10 Apr 2023 | Toronto, Ontario, Canada | ||
Transcarent | $200M | 11 Jan 2022 | San Francisco, California, United States | ||
Vori Health | $15M | 07 Jul 2021 | San Francisco, California, United States | ||
Recursion Pharmaceuticals | $121M | 15 Jul 2019 | Salt Lake City, Utah, United States | ||
Redox | $33M | 17 Apr 2019 | Madison, Wisconsin, United States | ||
Zebra Medical Vision | $30M | 07 Jun 2018 | Israel, North District, Israel | ||
Tissue Analytics | $5M | 16 Jan 2018 | Baltimore, Maryland, United States | ||
Empiric Health | $3M | 29 Nov 2017 | Salt Lake City, Utah, United States |
– Vori Health announced additional Series A funding from Intermountain Healthcare, Ascension Ventures, and Echo Health Ventures, bringing the total round size to over $50M.
– The round was led by NEA with participation from current investors AlleyCorp and Max Ventures.
– With these strategic partners, Vori Health will continue to expand its full-stack medical offering across the U.S. and will always welcome forward-thinking partners to join forces on this journey to transform care delivery across the nation and beyond.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Foodsmart by Zipongo | $10M | 31 Jan 2024 | San Francisco, California, United States | ||
CTRL Therapeutics | $10M | 10 Apr 2023 | Toronto, Ontario, Canada | ||
Transcarent | $200M | 11 Jan 2022 | San Francisco, California, United States | ||
Vori Health | $15M | 07 Jul 2021 | San Francisco, California, United States | ||
Recursion Pharmaceuticals | $121M | 15 Jul 2019 | Salt Lake City, Utah, United States | ||
Redox | $33M | 17 Apr 2019 | Madison, Wisconsin, United States | ||
Zebra Medical Vision | $30M | 07 Jun 2018 | Israel, North District, Israel | ||
Tissue Analytics | $5M | 16 Jan 2018 | Baltimore, Maryland, United States | ||
Empiric Health | $3M | 29 Nov 2017 | Salt Lake City, Utah, United States |